Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant for Acute HAE Attacks (FAST-3)
NCT00912093Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2009
- Primary completion
- Oct 2010
- Modality
- Peptides, Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of icatibant in hereditary angioedema (HAE), sponsored by Takeda. Started Jul 2009; status: completed.
02
Drugs
icatibant
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT00912093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912093.